Hydroxycarbamide is an antineoplastic agent and ribonucleotide reductase inhibitor widely utilized in the treatment of conditions such as sickle cell disease, chronic myelogenous leukemia, cervical cancer,… Read more
Hydroxycarbamide is an antineoplastic agent and ribonucleotide reductase inhibitor widely utilized in the treatment of conditions such as sickle cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. Within this category, laboratories can access a comprehensive range of high-quality reference standards essential for rigorous quality control and pharmaceutical analysis. This collection includes pharmacopeial and non-pharmacopeial impurities, alongside stable isotope labelled compounds, which are critical for conducting accurate impurity profiling and validating analytical methods. By incorporating these materials into development and stability testing protocols, researchers ensure the reliable identification and quantification of degradation products and metabolites. These reference materials support adherence to regulatory standards during the development and manufacturing of hydroxycarbamide drug products, facilitating precision in analytical workflows and safeguarding the integrity of pharmaceutical testing processes.